• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Iranian Journal of Immunology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 15 (2018)
Volume Volume 14 (2017)
Volume Volume 13 (2016)
Volume Volume 12 (2015)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 11 (2014)
Volume Volume 10 (2013)
Volume Volume 9 (2012)
Volume Volume 8 (2011)
Volume Volume 7 (2010)
Volume Volume 6 (2009)
Volume Volume 5 (2008)
Volume Volume 4 (2007)
Volume Volume 3 (2006)
Volume Volume 2 (2005)
Volume Volume 1 (2004)
Rafiee, M., Gharagozloo, M., Ghahiri, A., Mehrabian, F., Maracy, M., Kouhpayeh, S., Pieper, I., Rezaei, A. (2015). Altered Th17/Treg Ratio in Recurrent Miscarriage after Treatment with Paternal Lymphocytes and Vitamin D3: a Double- Blind Placebo-Controlled Study. Iranian Journal of Immunology, 12(4), 252-262.
Mitra Rafiee; Marjan Gharagozloo; Ataollah Ghahiri; Ferdous Mehrabian; Mohammad R. Maracy; Shirin Kouhpayeh; Ina Laura Pieper; Abbas Rezaei. "Altered Th17/Treg Ratio in Recurrent Miscarriage after Treatment with Paternal Lymphocytes and Vitamin D3: a Double- Blind Placebo-Controlled Study". Iranian Journal of Immunology, 12, 4, 2015, 252-262.
Rafiee, M., Gharagozloo, M., Ghahiri, A., Mehrabian, F., Maracy, M., Kouhpayeh, S., Pieper, I., Rezaei, A. (2015). 'Altered Th17/Treg Ratio in Recurrent Miscarriage after Treatment with Paternal Lymphocytes and Vitamin D3: a Double- Blind Placebo-Controlled Study', Iranian Journal of Immunology, 12(4), pp. 252-262.
Rafiee, M., Gharagozloo, M., Ghahiri, A., Mehrabian, F., Maracy, M., Kouhpayeh, S., Pieper, I., Rezaei, A. Altered Th17/Treg Ratio in Recurrent Miscarriage after Treatment with Paternal Lymphocytes and Vitamin D3: a Double- Blind Placebo-Controlled Study. Iranian Journal of Immunology, 2015; 12(4): 252-262.

Altered Th17/Treg Ratio in Recurrent Miscarriage after Treatment with Paternal Lymphocytes and Vitamin D3: a Double- Blind Placebo-Controlled Study

Article 3, Volume 12, Issue 4, Autumn 2015, Page 252-262  XML PDF (365.79 K)
Document Type: Original Article
Authors
Mitra Rafiee1; Marjan Gharagozloo1; Ataollah Ghahiri2; Ferdous Mehrabian2; Mohammad R. Maracy3; Shirin Kouhpayeh1; Ina Laura Pieper4; Abbas Rezaei email 1
1Department of Immunology, School of Medicine
2Department of Gynecology and Obstetrics, Al-Zahra University Hospital
3Department of Community Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
4Institute of Life Science, College of Medicine, Swansea University, Swansea, United Kingdom
Abstract
Background: Recurrent miscarriage (RM) affects 2-5% of pregnant women. Paternal lymphocyte immunotherapy is a common treatment for RM patients but the outcome has not been consistent. Therefore, combined therapy with other immunosuppressive drugs such as 1 a, 25-dihydroxy-vitamin-D3 (vitamin D3) may improve the outcome.
Objectives:
To investigate the effect of vitamin D3 on the balance of two essential T cells subsets, T helper (Th) 17 and T regulatory (Treg) cells, which contribute to the immune tolerance during pregnancy.
Methods:
The expression levels of CD4 and forkhead box protein 3 (FOXP3) in Treg cells, and the expression levels of CD4 and IL- 17 in Th17 cells, were evaluated pre- and 3 months post-immunotherapy in RM patients treated with a combination of paternal lymphocytes and vitamin D3 compared with RM patients receiving lymphocyte immunotherapy alone.
Results:
Vitamin D3 therapy decreased the frequency of Th17 cells in addition to reducing the Th17/Treg ratio in peripheral blood of RM patients compared with the control group (p <0.05).
Conclusion:
Considering that RM patients have a higher Th17/Treg ratio in peripheral blood, vitamin D3 may be a candidate therapeutic approach in this disease.
Keywords
Paternal Lymphocyte Therapy; Recurrent Miscarriage; Regulatory T; Cell; T Helper 17; Vitamin D3
Statistics
Article View: 1,121
PDF Download: 1,127
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by sinaweb.